|
Resolution: standard / high Figure 1.
Inhibition of HSG tumor cell adhesion to neural cells. A, various concentrations of cimetidine were added, and the interaction of HSG cells
with neural cells was examined. Phase-contrast microscopic pictures of representative
experiments are shown. The number of HSG cells adhering to the neural cell monolayer
was counted and is shown in the bar graph. B, NCAM antibody was added and the interaction of HSG cells with neural cells was examined.
Phase-contrast microscopic pictures of representative experiments are shown. The number
of HSG cells adhering to the neural cell monolayer was counted and is shown in the
bar graph. The label 'HSG (treated with MAb NCAM)-neural cell interaction' and the
black column in the graph indicate the number of HSG cells adhering to the neural
cells when the HSG cells were preincubated with the MAb NCAM. The label 'HSG-neural
cell (treated with MAb NCAM) interaction' and the gray column in the graph indicate
the number of HSG cells adhering to the neural cells when the neural cells were preincubated
with the MAb NCAM. ICAM-1 antibody was also added, and the results are shown as a
label 'HSG (treated with MAb ICAM-1)-neural cell interaction' and in the diagonally
shaded column (n = 3 experiments; means ± SD).
Fukuda et al. BMC Cancer 2008 8:376 doi:10.1186/1471-2407-8-376 |